Technology and Products

Nanotechnology and Medicine

Nanotechnology is often hailed as being revolutionary, and it has the potential to impact almost every area of society. Nanotechnology involves manipulating properties and structures at the nanoscale, often involving dimensions that are just tiny fractions of the width of a human hair. Nanotechnology is already being used in products in its passive form, such as cosmetics and sun screens. It's expected that new phases of products, such as better batteries and improved electronics equipment, will be developed and have far-reaching implications in the future.

Nanotechnology medical developments over the coming years will have a wide variety of uses and could potentially save a great number of lives. Nanotechnology is already moving from being used in passive structures to active structures, through more targeted drug therapies or "smart drugs." These new drug therapies have already been shown to cause fewer side effects and be more effective than traditional therapies.

In the future, nanotechnology will also aid in the formation of molecular systems that may be strikingly similar to living systems. These molecular structures could be the basis for the regeneration or replacement of body parts that are currently lost to infection, accident or disease. These predictions have great significance not only in encouraging nanotechnology research and development, but also in determining a means of oversight. The number of products approaching the United States Food and Drug Administration approval and review process is likely to grow as time moves forward and new nanotechnology medical applications are developed.

AB (Wuhan) Biotech Co. Ltd.'s core is its proprietary Nano-amplification technology and its application in integrated diagnostic bio-chips to be used for bimolecular detection to provide a hyper-sensitive and low-cost innovative application platform, particularly for various infectious and cardiovascular diseases. Our proprietary technologies and extensive experience in antibody (pairs) development are the keys to successfully developing a rapid immuno-test device.

Areas of Focus: Cardiovascular and Infectious Diseases

AB (Wuhan) Biotech Co. Ltd. has developed two diagnostic kits or rapid test devices for cardiovascular diseases. The first product in our pipeline is a rapid test device for early diagnosis of acute myocardial infarction (AMI). Another is a test kit for the diagnosis of hypertriglyceridemia.

The best time frame to treat AMI is within the first three hours of it being identified. However, most AMI treatments are delayed due to the limitation of diagnostic tools, poor facilities at small community and rural hospitals in China, and patients' poor self-protective consciousness. Our product is designed to solve those problems.

It's specific, sensitive, simple and fast, with no requirement for any special equipment or apparatus. This provides AMI patients with an efficient, convenient and inexpensive tool to self-test at home, make quick checks in hospital emergency rooms, and enable fast screening tests in community or rural hospitals.

AB (Wuhan) Biotech Co. Ltd. can use a panel of antibodies/antigens to detect infectious diseases in patients instead of relying on just one single antibody/antigen. It can also develop several panels that cover different groups of infectious diseases. By using a properly selected panel in our test systems, we believe their reliability will be superior to a single pathogen/marker test.